Does INFLIXIMAB Cause Prostate cancer? 376 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Prostate cancer have been filed in association with INFLIXIMAB (Renflexis). This represents 0.3% of all adverse event reports for INFLIXIMAB.
376
Reports of Prostate cancer with INFLIXIMAB
0.3%
of all INFLIXIMAB reports
5
Deaths
64
Hospitalizations
How Dangerous Is Prostate cancer From INFLIXIMAB?
Of the 376 reports, 5 (1.3%) resulted in death, 64 (17.0%) required hospitalization, and 16 (4.3%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 376 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
LENALIDOMIDE (366)
PREDNISONE (317)
RITUXIMAB (317)
Which INFLIXIMAB Alternatives Have Lower Prostate cancer Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT